Miris Launches the Human Milk Analyzer™ in the U.S.

As MedTech company Miris received clearance by US Food and Drug Administration (FDA) to market its Miris Human Milk Analyzer™ (HMA) in December, doctors in the US for the first time have access to a test to help analyze the nutrients in human milk. Today, the company is launching the Miris HMA™ in the U.S. with a launch party and panel discussion in Baltimore.

Miris - the global leader in human milk analysis, is today celebrating the launch of the Human Milk Analyzer™ (HMA) in Baltimore. The Miris HMA™ is the first instrument that has been approved as a diagnostic medical device for analyzing human milk nutrients in the U.S.

"For nearly 20 years, Miris has been focusing on developing instruments and solutions for milk analysis, says Camilla Myhre Sandberg, CEO Miris. "U.S. represents a tremendous opportunity for us, given its significant market size, the growing interest for optimizing nutrition for preterm infants, and an active entrepreneurship landscape. The FDA approval of Miris HMA™ forms another bold step to continue to ensure the best possible outcome for premature babies and we are happy to celebrate the approval with a launch party in Baltimore, says Camilla Myhre Sandberg”

The Miris Human Milk Analyzer™ uses an infrared spectroscopy system to analyze samples of humanmilk and provide a quantitative measurement of fat, protein and total carbohydrate content as well as calculations of the total solids and energy content contained in the milk. Data reviewed by FDA showed that the Miris Human Milk Analyzer test was effective at determining levels of protein, fat and carbohydrate in the milk. This is a prescription device intended for use by trained health care personnel at clinical laboratories.

For more information:
Camilla Myhre Sandberg, VD Miris Holding AB
Cell phone: +46 18-14 69 07
E-mail: camilla.sandberg@mirissolutions.com